Using unprecedented knowledge of the antiviral nucleoside arena, Cocrystal Pharma’s therapies target high-mutating viral diseases such as Influenza, Hepatitis C, Norovirus and more.
Our proprietary technologies enable the creation of first- and best-in-class antiviral products.
Our development programs include a wide variety of serious and/or chronic viral diseases such as Influenza and Hepatitis C.
Cocrystal Pharma uses proprietary and unique nucleoside chemistry combined with Nobel Prize winning expertise to target viral diseases.
View our latest Corporate Presentation
Be the first to receive breaking news